Tianjie Liu

#277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Loss of CYLD on Chromosome 16q Impairs Homologous Recombination and Genomic Stability Through TIRR Degradation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 13, 2026

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage.

Journal: Cancer cell

Published: April 25, 2025

CDC20-Mediated Selective Autophagy Degradation of PBRM1 Affects Immunotherapy for Renal Cell Carcinoma.

CDC20-Mediated Selective Autophagy Degradation of PBRM1 Affects Immunotherapy for Renal Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 15, 2024

CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.

CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.

Journal: Science advances

Published: May 23, 2024

PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer.

PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer.

Journal: Nature cell biology

Published: May 03, 2024

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1.

Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1.

Journal: Cell metabolism

Published: April 29, 2024

DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity.

DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity.

Journal: Nature communications

Published: April 02, 2024

Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma.

Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma.

Journal: Current cancer drug targets

Published: August 26, 2023

CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression.

CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression.

Journal: Cell death & disease

Published: July 12, 2023

MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.

MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.

Journal: Nature communications

Published: June 24, 2023

Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy.

Targeting LYPLAL1-mediated cGAS depalmitoylation enhances the response to anti-tumor immunotherapy.

Journal: Molecular cell

Published: January 18, 2023

FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.

FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner.

Journal: Cancer research

Published: September 15, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026